• TLDR Biotech
  • Posts
  • Biotech & Pharma Updates | November 10 - 11, 2024

Biotech & Pharma Updates | November 10 - 11, 2024

AbbVie may be feeling buyer's remorse as $8.9B Cereval buy delivers two Ph2 misses, IDEAYA Biosciences exercises licensing option for Biocytogen ADC asset, Novavax flu, COVID-19 vaccines clinical holds lifted, Novelty Nobility $24.8M Series C for solid tumour ADCs, Evotec becomes alleged acquisition target of PE firm Triton Partners, Doctors Without Borders pushes insulin pen makers to offer $1 pens in low and middle-income countries, 23andMe cuts 40% of their staff, Cigna denies considering Humana acquisition, Rapt Therapeutics drops autoimmune small molecule after negative FDA feedback

In partnership with

All the top Biotech & Pharma news in one daily newsletter.

Want to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

Looking to reach an audience of 1300+ biotech and pharma professionals? Let’s chat. 👍

⬇️ The Good News ⬇️

THE GOOD
Approvals & Labels

Zeta Surgical lands expanded FDA clearance for “GPS-like” mixed-reality brain surgery navigation platform
Brain surgery, mixed reality, computer vision, AI - Read more

THE GOOD
Business Development

IDEAYA Biosciences exercises exclusive licensing option for Biocytogen’s ADC IDE034
Antibody-drug conjugate, solid tumor, cancer - Read more

THE GOOD
Clinical Trials

Relief Therapeutics positive final results for RLF-TD011 proof-of-concept trial in epidermolysis bullosa
Small mlecule, epidermolysis bullosa - Read more

Gan & Lee Pharmaceuticals GZR18 demonstrated “significant reduction in body weight” in Ph2 clinical trial of obese, overweight Chinese adults
GLP-1, obesity - Read more

Kanvas Bio posts promising clinical data in fecal microbiota transplantation effects on anti-PD-1 refractory cancers
Fecal microbiota transplantation, cancer, drug resistance - Read more

Novavax COVID-19, flu vaccines clinical holds lifted by the FDA
Vaccine, flu, COVID-19 - Read more

Boston Scientific resumes pulse-field ablation clinical trials in atrial fibrillation
Medical device, atrial fibrillation, pulsed field ablation - Read more

Be part of a healthcare breakthrough.

Cizzle Biotech is evolving lung cancer detection with our patented, 95% accurate test. Our industry-leading partnerships and progress make this an important time to grow. Your support could help accelerate this life-saving science and bring it to patients worldwide.

Read the Offering information carefully before investing. It contains details of the issuer’s business, risks, charges, expenses, and other information, which should be considered before investing. Obtain a Form C and Offering Memorandum at invest.cizzlebio.com

⬇️ More Good News ⬇️

THE GOOD
Fundraises

Novelty Nobility 23.3B KRW ($24.8M) Series C, initiating ADC NN3201 Ph1 trial next year
Antibody-drug conjugate, solid tumor, cancer - Read more [Press release in Korean]

EpiBone undisclosed equity raise, regenerative medicine focused on skeletal reconstruction
Stem cells, 3D bioprinting, bone and osteochondral reconstruction - Read more

THE GOOD
Investments

Genscript ProBio builds logistics hub in Australia amongst increasing US scrutiny to China ties
CDMO, manufacturing, reagents, logistics hub, Biosecure - Read more

THE GOOD
Mergers & Acquisitions

Evotec is an alleged acquisition target by private equity firm Triton Partners
CRO, CDMO, takeover rumors - Read more

General Catalyst to acquire Ohio-based hospital system Summa Health for $485M
Healthcare, hospital system - Read more

THE GOOD
Partnerships

ALK-Abelló purchases marketing right to ARS Pharmaceuticals’s EURneffy worldwide (except for US, Australia, New Zealand, Japan, China) for $145M upfront, $320M biobucks
Small molecule, anaphylaxis, nasal spray - Read more

THE GOOD
Patient Access

Doctors Without Borders (MSF) demands insulin pen makers Sanofi, Eli Lilly, Novo Nordisk reduce device costs to $1 in low- and middle-income countries
Insulin, diabetes, insulin pen - Read more

THE GOOD
Research

Lunit’s AI-based tumor biopsy analysis tool can help predict rare tumor responses to checkpoint inhibitors according to research from MD Anderson Cancer Center
Biopsy analysis, cancer, tumor microenvironment, AI - Read more

MD Anderson Cancer Center launches cell therapy discovery & clinical research institute with initial $80M, goal of $150M total funding (philanthropic and institutional funds)
Cell therapy, drug discovery, drug development, R&D - Read more

ENJOYING THESE NEWSLETTERS?
Support TLDR Biotech🧬🦠🔬 

I’m offering this newsletter for free so it can get out to as many people as possible.

If you’re getting value out of these daily compilations, please consider a paid subscription (only $5/month) to support my continued work on this project.*

*Best of all, it’s a work-related news source that you can likely expense. 😉 

⬇️ The Bad News ⬇️

THE BAD
Clinical Trials

AbbVie’s $8.9B Cereval buy is looking like a complete dud after emraclidine flops in two key Ph2 trials
Small molecule, schizophrenia - Read more

THE BAD
Lawsuits

Aurion Biotech IPO plans go off-track as investor Alcon sues
Cell therapy, corneal endothelial dystrophies, eye disease - Read more [Paywall]

THE BAD
Layoffs

23andMe shutters therapeutic division with accompanying layoffs (40% of total staff)
Genetic testing, drug discovery - Read more

ThermoFisher telegraphs 160 layoffs across three viral vector facilities (with one of these facilities full shuttering)
Viral vectors, manufacturing - Read more

THE BAD
Mergers & Acquisitions

Cigna unequivocally confirms that it is not seeking an acquisition of Humana
Health insurance - Read more

THE BAD
Strategic Plans

Rapt Therapeutics throws in the towel on RPT193 development after negative FDA feedback, stock nearly halves
Small molecule, atopic dermatitis, asthma - Read more

⬇️ The Ugly News ⬇️

THE UGLY
Earnings & Finances

Assertio and activist investor The Buxton Helmsley Group trade blows over fraud allegations
Small molecule, short position, activist investor - Read more [Paywall]

You’re all caught up on the latest Pharma & Biotech News!

sign language pneumonia GIF by Sign with Robert

November 12th is World Pneumonia Day. | Gif: signwithrobert on Giphy

TLDR Biotech wants to hear from you! 📣

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

Last thing - if you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here